481
Views
16
CrossRef citations to date
0
Altmetric
Review

Chemical management of levodopa-induced dyskinesia in Parkinson’s disease patients

, , &
Pages 219-230 | Received 20 Jul 2018, Accepted 30 Oct 2018, Published online: 09 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yuan Li, Jiamin Zhu, Peng Sang, Yan Bai, Jinrong Lu, Hong Sun & Shun Wang. (2023) Effect of Tiaoshen Changzhi acupuncture on behavior and striatum ΔFosB in rats with levodopa-induced dyskinesias. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-15.
Read now
Sohaila AlShimemeri, Susan H Fox & Naomi P Visanji. (2020) Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update. Expert Opinion on Emerging Drugs 25:2, pages 131-144.
Read now

Articles from other publishers (14)

Athira Anirudhan, S. Mahema, Sheikh F. Ahmad, Talha Bin Emran, Shiek S. S. J. Ahmed & Prabu Paramasivam. (2023) Screening of Crucial Cytosolicproteins Interconnecting the Endoplasmic Reticulum and Mitochondria in Parkinson’s Disease and the Impact of Anti-Parkinson Drugs in the Preservation of Organelle Connectivity. Brain Sciences 13:11, pages 1551.
Crossref
Anna Sauerbier, Alexandra Gronostay & Haidar S. Dafsari. (2023) SOP: acute hyperkinetic movement disorders. Neurological Research and Practice 5:1.
Crossref
Thian-Sze Wong, Guangzhi Li, Shiliang Li, Wei Gao, Geng Chen, Shiyi Gan, Manzhan Zhang, Honglin Li, Song Wu & Yang Du. (2023) G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduction and Targeted Therapy 8:1.
Crossref
S. V. Shtaimets, N. G. Zhukova, M. M. Katina, I. A. Zhukova, A. Е. Agasheva & D. A. Novotnyy. (2023) Integrative Analysis of Predictors for Unfavorable Course of Parkinson Disease According to Medical Care Assessment: Cohort Retrospective Study. Kuban Scientific Medical Bulletin 30:1, pages 69-77.
Crossref
Vladana Marković, Iva Stanković, Saša Radovanović, Igor Petrović, Milica Ječmenica Lukić, Nataša Dragašević Mišković, Marina Svetel & Vladimir Kostić. (2022) Gait alterations in Parkinson’s disease at the stage of hemiparkinsonism—A longitudinal study. PLOS ONE 17:7, pages e0269886.
Crossref
Yassamine Ouerdane, Mohamed Y. Hassaballah, Abdalrazeq Nagah, Tarek M. Ibrahim, Hosny A. H. Mohamed, Areej El-Baz & Mohamed S. Attia. (2022) Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications. Pharmaceuticals 15:1, pages 76.
Crossref
Yi Wu, Xue-bing Cao, Wei-qi Zeng, Heng Zhai, Xiao-qian Zhang, Xiao-man Yang, Chi Cheng, Jia-ling Wang, Xiao-mei Yang & Yan Xu. (2021) Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review. Frontiers in Neurology 12.
Crossref
Ziqing Shi, Ian J. Bamford, Jonathan W. McKinley, Suma Priya Sudarsana Devi, Annie Vahedipour & Nigel S. Bamford. (2020) Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice. Brain Sciences 10:12, pages 903.
Crossref
Pradeep Hanumanthappa, Arpitha Ashok, Inderjit Prakash, Carmel I. Priya, Julie Zinzala, Vidya V. Marigowda & Aparna H. Sosalegowda. (2020) In silico and In vivo Evaluation of Oxidative Stress Inhibitors Against Parkinson's Disease using the C. elegans Model. Combinatorial Chemistry & High Throughput Screening 23:8, pages 814-826.
Crossref
Daniela Mercatelli, Erwan Bezard, Roberto Eleopra, Nurulain T. Zaveri & Michele Morari. (2020) Managing Parkinson's disease: moving ON with NOP. British Journal of Pharmacology 177:1, pages 28-47.
Crossref
Pengfei Yang, Joel S. Perlmutter, Tammie L.S. Benzinger, John C. Morris & Jinbin Xu. (2020) Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?. Ageing Research Reviews 57, pages 100994.
Crossref
Shi‐Ying Fan, Kai‐Liang Wang, Wei Hu, Robert S. Eisinger, Alexander Han, Chun‐Lei Han, Qiao Wang, Shimabukuro Michitomo, Jian‐Guo Zhang, Feng Wang, Adolfo Ramirez‐Zamora & Fan‐Gang Meng. (2019) Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia. Annals of Clinical and Translational Neurology 7:1, pages 59-68.
Crossref
Claudia Carrarini, Mirella Russo, Fedele Dono, Martina Di Pietro, Marianna G. Rispoli, Vincenzo Di Stefano, Laura Ferri, Filomena Barbone, Michela Vitale, Astrid Thomas, Stefano Luca Sensi, Marco Onofrj & Laura Bonanni. (2019) A Stage-Based Approach to Therapy in Parkinson’s Disease. Biomolecules 9:8, pages 388.
Crossref
Fabio Bello, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili & Wilma Quaglia. (2019) Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease. Biomolecules 9:4, pages 142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.